Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytoskeleton-associated protein 4 pseudogene (ENSG00000226592)
- Target
- ENSG00000226592
- Molecular classification
- Pseudogene, Processed pseudogene, Non-coding RNA
01
Overview
The cytoskeleton-associated protein 4 pseudogene (ENSG00000226592) is a nonfunctional DNA sequence derived from reverse transcription and retrotransposition of the CAP4 mRNA into the genome, lacking introns and typical regulatory elements needed for functional protein expression[1][2][3]. Pseudogenes like this are noncoding, evolutionary relics with no confirmed biological activity, though rare examples exist of pseudogenes contributing to gene regulation at the RNA level[3][5]. The vast majority, including this one, are considered nonfunctional with respect to cell signaling, metabolism, or disease processes. This entry should not be used as a therapeutic target, and its inclusion typically indicates either a misinterpretation of gene lists or an error in target annotation[3][5].
- Other names
- ENSG00000226592CAP4P
02
Mechanism of action
Not applicable; pseudogenes are not druggable targets
03
Biological functions
No known protein-coding functionMay rarely affect gene regulation via RNA-level mechanisms such as RNA sponging or generation of small RNAsLargely considered genomic "junk" DNA, though some pseudogenes have minor regulatory roles
04
Disease associations
No direct established roleSome pseudogenes have been implicated in regulation relevant to cancer, but specific evidence for cytoskeleton-associated protein 4 pseudogene is lacking
Beyond the preview
Go deeper on Cytoskeleton-associated protein 4 pseudogene (ENSG00000226592).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytoskeleton-associated protein 4 pseudogene (ENSG00000226592).